Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Nature
|
August 2, 2013
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
Marcus Dorner, Joshua A Horwitz, Bridget M Donovan, et al.
Journal of Hepatology
|
May 7, 2016
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
Eva Billerbeck, Michiel C Mommersteeg, Amir Shlomai, et al.
NPJ Vaccines
|
January 9, 2021
Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design
Vanessa M Cowton, Ania M Owsianka, Valeria Fadda, et al.
Nature
|
June 10, 2011
A genetically humanized mouse model for hepatitis C virus infection
Marcus Dorner, Joshua A Horwitz, Justin B Robbins, et al.
Mbio
|
November 12, 2016
Expanding the Host Range of Hepatitis C Virus through Viral Adaptation
Markus von Schaewen, Marcus Dorner, Kathrin Hueging, et al.
Viruses
|
February 23, 2019
Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
Michela Mazzon, Ana Maria Ortega-Prieto, Douglas Imrie, et al.
Scientific Reports
|
November 4, 2020
Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Peter Jianrui Liu, James M Harris, Emanuele Marchi, et al.
Scientific Reports
|
August 26, 2020
Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Peter Jianrui Liu, James M Harris, Emanuele Marchi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2013
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
Joshua A Horwitz, Ariel Halper-Stromberg, Hugo Mouquet, et al.
Science Translational Medicine
|
September 19, 2014
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
Ype P de Jong, Marcus Dorner, Michiel C Mommersteeg, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Nature
|
August 2, 2013
Completion of the entire hepatitis C virus life cycle in genetically humanized mice
Marcus Dorner, Joshua A Horwitz, Bridget M Donovan, et al.
Journal of Hepatology
|
May 7, 2016
Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells
Eva Billerbeck, Michiel C Mommersteeg, Amir Shlomai, et al.
NPJ Vaccines
|
January 9, 2021
Development of a structural epitope mimic: an idiotypic approach to HCV vaccine design
Vanessa M Cowton, Ania M Owsianka, Valeria Fadda, et al.
Nature
|
June 10, 2011
A genetically humanized mouse model for hepatitis C virus infection
Marcus Dorner, Joshua A Horwitz, Justin B Robbins, et al.
Mbio
|
November 12, 2016
Expanding the Host Range of Hepatitis C Virus through Viral Adaptation
Markus von Schaewen, Marcus Dorner, Kathrin Hueging, et al.
Viruses
|
February 23, 2019
Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
Michela Mazzon, Ana Maria Ortega-Prieto, Douglas Imrie, et al.
Scientific Reports
|
November 4, 2020
Author Correction: Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Peter Jianrui Liu, James M Harris, Emanuele Marchi, et al.
Scientific Reports
|
August 26, 2020
Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
Peter Jianrui Liu, James M Harris, Emanuele Marchi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 18, 2013
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
Joshua A Horwitz, Ariel Halper-Stromberg, Hugo Mouquet, et al.
Science Translational Medicine
|
September 19, 2014
Broadly neutralizing antibodies abrogate established hepatitis C virus infection
Ype P de Jong, Marcus Dorner, Michiel C Mommersteeg, et al.
Page
of 5